Novel therapeutics in myeloproliferative neoplasms
Abstract Hyperactive signaling of the Janus-Associated Kinase/Signal Transducers and Activators of Transcription (JAK/STAT) pathway is central to the pathogenesis of Philadelphia-chromosome-negative myeloproliferative neoplasms (MPN), i.e., polycythemia vera (PV), essential thrombocythemia (ET), and...
| Príomhchruthaitheoirí: | , |
|---|---|
| Formáid: | Alt |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
BMC
2020-12-01
|
| Sraith: | Journal of Hematology & Oncology |
| Ábhair: | |
| Rochtain ar líne: | https://doi.org/10.1186/s13045-020-00995-y |